Everett E. Vokes to Neoplasms, Hormone-Dependent
This is a "connection" page, showing publications Everett E. Vokes has written about Neoplasms, Hormone-Dependent.
Connection Strength
0.070
-
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases. Clin Cancer Res. 2006 Mar 01; 12(5):1556-63.
Score: 0.070